[
    [
        {
            "time": "",
            "original_text": "这些股4月获北上资金净买入超10亿元",
            "features": {
                "keywords": [
                    "北上资金",
                    "净买入",
                    "4月"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "这些股4月获北上资金净买入超10亿元",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "IPO动态 | 康希诺频频融资未见产品上市，竞争力存疑未来三年难扭亏",
            "features": {
                "keywords": [
                    "康希诺",
                    "融资",
                    "竞争力",
                    "扭亏"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "IPO动态 | 康希诺频频融资未见产品上市，竞争力存疑未来三年难扭亏",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "北上资金这个胡汉三又杀回来了 逾500亿抄底净买入白酒双雄超80亿",
            "features": {
                "keywords": [
                    "北上资金",
                    "抄底",
                    "白酒",
                    "净买入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金这个胡汉三又杀回来了 逾500亿抄底净买入白酒双雄超80亿",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "北上资金这个胡汉三又杀回来了：逾500亿抄底、净买入白酒双雄超80亿、增仓这家钛白粉公司超10倍！",
            "features": {
                "keywords": [
                    "北上资金",
                    "抄底",
                    "白酒",
                    "钛白粉",
                    "增仓"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金这个胡汉三又杀回来了：逾500亿抄底、净买入白酒双雄超80亿、增仓这家钛白粉公司超10倍！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "宝盈一季度调仓观察：消费、医药、科技各有所爱",
            "features": {
                "keywords": [
                    "宝盈",
                    "调仓",
                    "消费",
                    "医药",
                    "科技"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "宝盈一季度调仓观察：消费、医药、科技各有所爱",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "股价创新高与业绩遭“双杀” 机构和高管趁机减持华兰生物 盈利能力下降",
            "features": {
                "keywords": [
                    "股价",
                    "创新高",
                    "业绩",
                    "双杀",
                    "减持",
                    "华兰生物",
                    "盈利能力"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "股价创新高与业绩遭“双杀” 机构和高管趁机减持华兰生物 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[国信医药】疫情带动下，检测板块迎来业绩和估值的双击（周观点）",
            "features": {
                "keywords": [
                    "国信医药",
                    "疫情",
                    "检测板块",
                    "业绩",
                    "估值",
                    "双击"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[国信医药】疫情带动下，检测板块迎来业绩和估值的双击（周观点）",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[国元医药|点评】昭衍新药2020半年报点评：Q2保持高速增长态势，全年有望维持高景气",
            "features": {
                "keywords": [
                    "昭衍新药",
                    "半年报",
                    "Q2",
                    "高增长",
                    "高景气"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[国元医药|点评】昭衍新药2020半年报点评：Q2保持高速增长态势，全年有望维持高景气",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "多只疫苗龙头一季度业绩不及预期 机构称疫情有望打开疫苗市场天花板 盈利能力下降",
            "features": {
                "keywords": [
                    "疫苗",
                    "龙头",
                    "业绩",
                    "不及预期",
                    "疫情",
                    "市场天花板",
                    "盈利能力"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "多只疫苗龙头一季度业绩不及预期 机构称疫情有望打开疫苗市场天花板 盈利能力下降",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "分拆上市又要火！10余家上市公司密集公布分拆子公司创业板上市计划，有何影响？",
            "features": {
                "keywords": [
                    "分拆上市",
                    "创业板",
                    "计划",
                    "影响"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "分拆上市又要火！10余家上市公司密集公布分拆子公司创业板上市计划，有何影响？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "全球新冠疫苗竞速白热化：机构重金投入",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "竞速",
                    "白热化",
                    "机构",
                    "重金投入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "全球新冠疫苗竞速白热化：机构重金投入",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "全球新冠疫苗竞速白热化：五类技术齐发，机构重金投入",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "竞速",
                    "白热化",
                    "五类技术",
                    "机构",
                    "重金投入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "全球新冠疫苗竞速白热化：五类技术齐发，机构重金投入",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]